Atlas Trials

Safety and Immunogenicity of COVID-19 Vaccine Administered in Older Adults

Clinical trial NCT05012800 · UNKNOWN

Trial details

NCT number
NCT05012800
Sponsor
Beijing 302 Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
COVID-19 VaccineOlder Adults
Start date
2021-07-28
Primary completion
2022-08-31
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.